Polymorphisms of the IL1-receptor antagonist gene (IL1RN) are associated with multiple markers of systemic inflammation

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 28, Issue 7, 2008, Pages 1407-1412

  Reiner, Alexander P ^a   Wurfel, Mark M ^a   Lange, Leslie A ^c   Carlson, Christopher S ^b   Nord, Alex S ^a   Carty, Cara L ^a   Rieder, Mark J ^a   Desmarais, Cindy ^a   Jenny, Nancy S ^d   Iribarren, Carlos ^e   Walston, Jeremy D ^f   Williams, O Dale ^g   Nickerson, Deborah A ^a   Jarvik, Gail P ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d UNIVERSITY OF VERMONT   (United States)

^e DIVISION OF RESEARCH   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g University of Alabama at Birmingham   (United States)

Author keywords

C reactive protein; Fibrinogen; IL 1 receptor antagonist; Inflammation

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; AUTACOID; BIOLOGICAL MARKER; IL1RN PROTEIN, HUMAN;

ADULT; AGED; ALLELE; ARTICLE; CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION; GENE STRUCTURE; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SCREENING; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; INFLAMMATION; META ANALYSIS; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; REPRODUCIBILITY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; UNITED STATES;

EID: 45049083638     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.108.167437     Document Type: Article

References (29)

1. Gabay C, Rushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448-454.
2. Pearson TA, Mensah GA, Hong Y, Smith SC Jr; CDC; AHA. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: overview. Circulation. 2004;110:e543-e544.
3. Ganapathi MK, Rzewnicki D, Samols D, Jiang SL, Kushner I. Effect of combinations of cytokines and hormones on synthesis of serum amyloid A and C-reactive protein in Hep 3B cells. J Immunol. 1992;147: 1261-1265.
4. Mackiewicz A, Speroff T, Ganapathi MK, Kushner I. Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines. J Immunol. 1991;146:3032-3037.
5. Agrawal A, Samols D, Kushner I. Transcription factor c-Rel enhances C-reactive protein, expression by facilitating the binding of C/EBPbeta to the promoter. Mol Immunol. 2003;40:373-380.
6. Carlson CS, Force-Aldred S, Lee PK, Tracy KP, Schwartz SM, Rieder MJ, Liu K, Williams OD, Iribarren C, Lewis CE, Fornage M, Boerwinkle E, Gross M, Jaquish C, Nickerson. DA, Myers R, Siscovick DS, Reiner AP. Polymorphisms within the C Reactive Protein promoter region are associated with plasma CRP levels. Am J Hum. Genet. 2005;77:64-77.
7. Hage FG, Szalai AJ. C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk. J Am Coll Cardiol. 2007;50:1115-1122.
8. Pankow JS, Folsom AR, Cushman M, et al. Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atherosclerosis. 2001;154:681-689.
9. Worns MA, Victor A, Galle PR, Hohler T. Genetic and environmental contributions to plasma C-reactive protein and IL-6 levels - a study in twins. Genes Immun. 2006;7:600-605.
10. MacGregor AJ, Gallimore JR, Spector TD, Pepys MB. Genetic effects on baseline values of C-reactive protein and serum amyloid a protein: a comparison of monozygotic and dizygotic twins. Clin Chem. 2004;50: 130-134.
11. Retterstol L, Eikvar L, Berg K. A twin study of C-Reactive Protein, compared to other risk factors for coronary heart disease. Atherosclerosis. 2003;169:279-282.
12. Scheet P, Stephens M. A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase. Am J Hum. Genet. 2006;78:629-644.
13. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Mailer J, Sklar P, de Bakker PI, Daly MJ, Sham PC. PLINR: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559-575.
14. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
15. Servin B, Stephens M. Imputation-based analysis of association studies: candidate regions and quantitative traits. PLoS Genet. 2007;3:e114.
16. Tarlow JK, Blakemore AI, Lennard A, Solari R, Hughes HN, Steinkasserer A, Duff GW. Polymorphism in human IL-I receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum. Genet. 1993;91:403-404.
17. Broeckel U, Hengstenberg C, Mayer B, Maresso K, Gaudet D, Seda O, Tremblay J, Holmer S, Erdmann. J, Glockner C, Harrison M, Martin LJ, Williams JT, Schmitz G, Riegger GA, Jacob HJ, Hamet P, Schunkert H. A locus on chromosome 10 influences C-reactive protein levels in two independent populations. Hum. Genet. 2007;122:95-102.
18. Latkovskis G, Licis N, Ralnins U. C-reactive protein levels and common polymorphisms of the IL-1 gene cluster and IL-6 gene in patients with coronary heart disease. Eur J Immunogenet. 2004;31:207-213.
19. Berger P, McConnell JP, Nunn M, Romman RS, Sorrell J, Stephenson K, Duff GW. C-reactive protein levels are influenced by common IL-1 gene variations. Cytokine. 2002;17:171-174.
20. Rafiq S, Stevens K, Hurst AJ, Murray A, Henley W, Weedon MN, Bandinelli S, Corsi AM, Guralnik JM, Ferruci L, Melzer D, Frayling TM. Common genetic variation in the gene encoding IL-I-receptor antagonist (IL-1RA) is associated with altered circulating IL-IRA levels. Genes Immun. 2007;8:344-351.
21. Arend WP. The balance between IL-I and IL-IRa in. disease. Cytokine Growth Factor Rev. 2002;13:323-340.
22. Malyak M, Smith MF Jr, Abel AA, Arend WP. Peripheral blood neutrophil production of IL-1 receptor antagonist and. IL-1 beta. J Clin Immunol. 1994;14:20-30.
23. Re F, Mengozzi M, Muzio M, Dinarello CA, Mantovani A, Colotta F. Expression of IL-1 receptor antagonist (il-1ra) by human circulating polymorphonuclear cells. Eur J Immunol. 1993;23:570-573.
24. Gabay C, Smith MF, Eidlen D, Arend. WP. IL 1 receptor antagonist (IL-IRa) is an. acute-phase protein. 7 Clin Invest. 1997;99:2930-2940.
25. Jenkins JK, Drong RF, Shuck ME, Bienkowski MJ, Slightom JL, Arend WP, Smith MF Jr. Intracellular IL-1 receptor antagonist promoter: cell type-specific and inducible regulatory regions. J Immunol. 1997;158: 748-755.
26. Larsen CM, Faulenbach M, Vaag A, Volund A, Ehses JA, Seifert B, Mandrup-Poulsen T, Donath MY. IL-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med. 2007;356:1517-1526.
27. Emsley HC, Smith CJ, Georgiou RF, Vail A, Hopkins SJ, Rothwell NJ, Tyrrell PJ; Acute Stroke Investigators. A randomised phase II study of IL-I receptor antagonist in acute stroke patients. J Neurol Neurosurg Psychiat. 2005;76:1366-1372.
28. Iqbal I, Fleischmann. R. Treatment of osteoarthritis with anakinra. Curr Rheumatol Rep. 2007;9:31-35.
29. Tolusso B, Pietrapertosa D, Morelli A, De Santis M, Gremese E, Farina G, Carniello SG, Del Frate M, Ferraccioli G. IL-1B and IL-1RN gene polymorphisms in rheumatoid arthritis: relationship with protein plasma levels and response to therapy. Pharmacogenomics. 2006;7:683-695.